Similar articles

• An alternative approach to determining therapeutic choices in advanced non-small cell lung carcinoma (NSCLC): maximizing the diagnostic procedure and the use of low-volume lung biopsies.

  Lim EH, Zhang SL, Yu K, Nga ME, Ahmed DA, Agasthian T, Wong PS, Chua GC, Wong D, Tan L, Seto KY, Yap WS, Low SP, Khoo KL, Chang A, Ng A, Tan P. Lim EH, et al. J Thorac Oncol. 2007 May;2(5):387-96. doi: 10.1097/01.JTO.0000268671.49378.c2. J Thorac Oncol. 2007. PMID: 17473653
• Molecular prognostication of non-small cell lung cancer.

  Tsao MS, Jablons DM. Tsao MS, et al. Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):4-7. doi: 10.1053/j.semtcvs.2013.01.007. Semin Thorac Cardiovasc Surg. 2013. PMID: 23800523 No abstract available.
• Molecular diagnostics in advanced NSCLC: trying to maximize a non-ideal situation.

  Lim EH, Tan P. Lim EH, et al. J Thorac Oncol. 2007 Aug;2(8):782. doi: 10.1097/JTO.0b013e31811f479d. J Thorac Oncol. 2007. PMID: 17762350 No abstract available.
• [Association of molecular biology of lung cancers and their metastasis and prognosis].

  Mao YS, Gao YN, He J. Mao YS, et al. Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):632-4. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17236563 Review. Chinese. No abstract available.
• Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.

  Dacic S. Dacic S. Expert Rev Mol Diagn. 2007 Jan;7(1):77-86. doi: 10.1586/14737159.7.1.77. Expert Rev Mol Diagn. 2007. PMID: 17187486 Review.